Mast cell sarcoma transdifferentiated from clonally-related T-lymphoblastic leukemia upon acquisition of
TP53
mutation and genetic complexity
Leuk Lymphoma
.
2021 Dec;62(13):3304-3307.
doi: 10.1080/10428194.2021.1950710.
Epub 2021 Jul 14.
Authors
Juehua Gao
1
,
Lucy Fu
1
,
Xinyan Lu
1
,
Madina Sukhanova
1
,
Olga Frankfurt
2
,
Arash Mohtashamian
3
,
Amy Chadburn
4
,
Lawrence Jennings
1
,
Barina Aqil
1
,
Qing Chen
1
,
Yi-Hua Chen
1
Affiliations
1
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
2
Hematology and Oncology, Hematology Oncology Division, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
3
Naval Medical Center San Diego, San Diego, CA, USA.
4
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
PMID:
34261406
DOI:
10.1080/10428194.2021.1950710
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Adult
Humans
Male
Mast-Cell Sarcoma* / genetics
Mutation
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
Tumor Suppressor Protein p53 / genetics
Substances
TP53 protein, human
Tumor Suppressor Protein p53